CEF-ONE-250
Description
- Contains Ceftriaxone 250 mg, a third-generation cephalosporin antibiotic
- Administered via IM or IV route for rapid action
- Broad-spectrum efficacy against both Gram-positive and Gram-negative organisms
- Indicated for respiratory, urinary, abdominal, skin, and bloodstream infections
- Once-daily dosing improves compliance and reduces hospital workload
- High tissue penetration ensures effective infection control
- Commonly used in both treatment and surgical prophylaxis
Composition
Ceftriaxone 250 mg
Benefits
CEF-ONE-250 offers rapid and effective treatment for various serious infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, septicemia, and meningitis. Its once-daily dosing provides ease of administration and enhances patient compliance. Ceftriaxone's high tissue penetration and long duration of action make it especially useful in hospital-based treatments where quick bacterial eradication is required. It is also frequently used as a perioperative prophylactic antibiotic in surgeries.
Introduction
CEF-ONE-250 is a sterile injectable formulation containing Ceftriaxone 250 mg, a third-generation cephalosporin antibiotic known for its broad-spectrum antibacterial activity. Ceftriaxone works by inhibiting bacterial cell wall synthesis, effectively killing a wide range of Gram-positive and Gram-negative bacteria. It is administered via intramuscular (IM) or intravenous (IV) injection and is commonly used in hospitals and clinical settings for treating moderate to severe bacterial infections. CEF-ONE-250 is well-regarded for its powerful action, prolonged half-life, and reliable therapeutic outcomes.
